MedDataX Logo

Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents

NCT ID: NCT00831883

Last Updated: 2012-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

59 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-02-28

Study Completion Date

2011-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Incarcerated adolescents represent a group at high risk for health consequences associated with risky sexual behaviors. Condom use is more common with non-main than main sex partners and substance use in conjunction with sexual risk also appears to vary by partner type. The research team will conduct a small randomized trial to pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use. Participants will be randomized to a 5 session HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model, or a 5 session healthy lifestyles psychoeducation intervention, and then reassessed 3 months after their access to the general community is reinstated. The main hypothesis is that participants in the HIV risk reduction intervention condition will have lower levels of sex-related HIV risk behavior and of substance use in conjunction with sexual risk, relative to those in a healthy lifestyles psychoeducation intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sexually Transmitted Diseases Substance-Related Disorders

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Adolescent Adolescent behavior Health behavior Sexual Behavior Incarceration Behavioral Intervention Risk Reduction Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Partner Specific IMB

partner-specific HIV risk reduction intervention

Group Type EXPERIMENTAL

Partner-Specific IMB-based HIV risk reduction intervention

Intervention Type BEHAVIORAL

5 session partner-specific HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model.

HLS

5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.

Group Type PLACEBO_COMPARATOR

Healthy Lifestyle

Intervention Type BEHAVIORAL

5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Partner-Specific IMB-based HIV risk reduction intervention

5 session partner-specific HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model.

Intervention Type BEHAVIORAL

Healthy Lifestyle

5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* English-speaking ability
* unprotected vaginal, anal, or oral intercourse at least once in the 6 months prior to incarceration or placement
* marijuana use disorders, other non-injection drug use disorders, or substance use by a sexual partner during a sexual episode in the six months prior to incarceration or placement
* sentence or placement length between 2 and 12 months
* must plan to remain in the area for the 6 months following their release from the facility
* must be willing to provide two pieces of contact information for follow-up

Exclusion Criteria

* signs of psychosis (assessed through clinical assessment)
Minimum Eligible Age

15 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Rhode Island

OTHER

Sponsor Role collaborator

Women and Infants Hospital of Rhode Island

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cynthia Rosengard

Cynthia Rosengard, Ph.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cynthia Rosengard, PhD, MPH

Role: PRINCIPAL_INVESTIGATOR

Women & Infants of Rhode Island

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Women & Infants Hospital of Rhode Island

Providence, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01DA022921-03

Identifier Type: NIH

Identifier Source: secondary_id

View Link

08-0128

Identifier Type: -

Identifier Source: org_study_id